Efficacy of HSV-TK/GCV system suicide gene therapy using SHED expressing modified HSV-TK against lung cancer brain metastases | Zendy

Tomoya Oishi | Zendy; Masahiko Ito | Zendy; Shinichiro Koizumi | Zendy; Makoto Horikawa | Zendy; Taisuke Yamamoto | Zendy; Satoru Yamagishi | Zendy; Tomohiro Yamasaki | Zendy; Tetsuro Sameshima | Zendy; Tetsuro Suzuki | Zendy; Haruhiko Sugimura | Zendy; Hiroki Namba | Zendy; Kazuhiko Kurozumi | Zendy

Open Access

Efficacy of HSV-TK/GCV system suicide gene therapy using SHED expressing modified HSV-TK against lung cancer brain metastases

Author(s) -

Tomoya Oishi,

Masahiko Ito,

Shinichiro Koizumi,

Makoto Horikawa,

Taisuke Yamamoto,

Satoru Yamagishi,

Tomohiro Yamasaki,

Tetsuro Sameshima,

Tetsuro Suzuki,

Haruhiko Sugimura,

Hiroki Namba,

Kazuhiko Kurozumi

Publication year - 2022

Publication title -

molecular therapy — methods and clinical development

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.285

H-Index - 32

ISSN - 2329-0501

DOI - 10.1016/j.omtm.2022.07.001

Subject(s) - suicide gene , bystander effect , thymidine kinase , cancer research , ganciclovir , genetic enhancement , mesenchymal stem cell , lung cancer , medicine , in vivo , herpes simplex virus , biology , immunology , pathology , virus , gene , human cytomegalovirus , microbiology and biotechnology , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog